Envestnet Asset Management Inc Zynex Inc Transaction History

Envestnet Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$9.53 - $16.8 $6,937 - $12,230	-728 Reduced 3.91%	17,899 $214,000
Q4 2022 Feb 07, 2023	SELL	$8.71 - $14.28 $15,294 - $25,075	-1,756 Reduced 8.62%	18,627 $259,000
Q3 2022 Nov 10, 2022	SELL	$7.19 - $9.91 $2,710 - $3,736	-377 Reduced 1.82%	20,383 $185,000
Q2 2022 Aug 03, 2022	BUY	$5.78 - $8.87 $119,992 - $184,141	20,760 New	20,760 $166,000
Q3 2021 Oct 07, 2021	SELL	$10.35 - $15.65 $111,811 - $169,066	-10,803 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$12.25 - $14.87 $7,190 - $8,728	587 Added 5.75%	10,803 $168,000
Q1 2021 May 04, 2021	SELL	$12.28 - $19.74 $7,232 - $11,626	-589 Reduced 5.45%	10,216 $156,000
Q4 2020 Feb 02, 2021	BUY	$11.65 - $17.94 $570 - $879	49 Added 0.46%	10,805 $145,000
Q3 2020 Oct 09, 2020	SELL	$12.98 - $25.98 $1,648 - $3,299	-127 Reduced 1.17%	10,756 $188,000
Q2 2020 Jul 08, 2020	BUY	$9.06 - $23.49 $98,599 - $255,641	10,883 New	10,883 $271,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.